|
1
|
Knauf C, Cani PD, Ait-Belgnaoui A, Benani
A, Dray C, Cabou C, Colom A, Uldry M, Rastrelli S, Sabatier E, et
al: Brain glucagon-like peptide 1 signaling controls the onset of
high-fat diet-induced insulin resistance and reduces energy
expenditure. Endocrinology. 149:4768–4777. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cummings DE and Schwartz MW: Genetics and
pathophysiology of human obesity. Annu Rev Med. 54:453–471. 2003.
View Article : Google Scholar
|
|
3
|
Alberti KG, Zimmet P and Shaw J; IDF
Epidemiology Task Force Consensus Group: The metabolic syndrome - a
new worldwide definition. Lancet. 366:1059–1062. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
French SA, Story M and Jeffery RW:
Environmental influences on eating and physical activity. Annu Rev
Public Health. 22:309–335. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wyatt SB, Winters KP and Dubbert PM:
Overweight and obesity: prevalence, consequences, and causes of a
growing public health problem. Am J Med Sci. 331:166–174. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Poitout V and Robertson RP: Minireview:
secondary beta-cell failure in type 2 diabetes - a convergence of
glucotoxicity and lipotoxicity. Endocrinology. 143:339–342.
2002.PubMed/NCBI
|
|
7
|
Prentki M, Joly E, El-Assaad W and Roduit
R: Malonyl-CoA signaling, lipid partitioning, and
glucolipotoxicity: role in β-cell adaptation and failure in the
etiology of diabetes. Diabetes. 51(Suppl 3): S405–S413. 2002.
View Article : Google Scholar
|
|
8
|
Kaiser N, Leibowitz G and Nesher R:
Glucotoxicity and beta-cell failure in type 2 diabetes mellitus. J
Pediatr Endocrinol Metab. 16:5–22. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakae J, Biggs WH III, Kitamura T, Cavenee
WK, Wright CV, Arden KC and Accili D: Regulation of insulin action
and pancreatic beta-cell function by mutated alleles of the gene
encoding forkhead transcription factor Foxo1. Nat Genet.
32:245–253. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sussel L, Kalamaras J, Hartigan-O'Connor
DJ, Meneses JJ, Pedersen RA, Rubenstein JL and German MS: Mice
lacking the homeodomain transcription factor Nkx2.2 have diabetes
due to arrested differentiation of pancreatic beta cells.
Development. 125:2213–2221. 1998.PubMed/NCBI
|
|
11
|
Withers DJ, Burks DJ, Towery HH, Altamuro
SL, Flint CL and White MF: Irs-2 coordinates Igf-1
receptor-mediated beta-cell development and peripheral insulin
signalling. Nat Genet. 23:32–40. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Offield MF, Jetton TL, Labosky PA, Ray M,
Stein RW, Magnuson MA, Hogan BL and Wright CV: PDX-1 is required
for pancreatic outgrowth and differentiation of the rostral
duodenum. Development. 122:983–995. 1996.PubMed/NCBI
|
|
13
|
Park JH, Stoffers DA, Nicholls RD and
Simmons RA: Development of type 2 diabetes following intrauterine
growth retardation in rats is associated with progressive
epigenetic silencing of Pdx1. J Clin Invest. 118:2316–2324.
2008.PubMed/NCBI
|
|
14
|
Brissova M, Blaha M, Spear C, Nicholson W,
Radhika A, Shiota M, Charron MJ, Wright CV and Powers AC: Reduced
PDX-1 expression impairs islet response to insulin resistance and
worsens glucose homeostasis. Am J Physiol Endocrinol Metab.
288:E707–E714. 2005. View Article : Google Scholar
|
|
15
|
Kulkarni RN, Jhala US, Winnay JN,
Krajewski S, Montminy M and Kahn CR: PDX-1 haploinsufficiency
limits the compensatory islet hyperplasia that occurs in response
to insulin resistance. J Clin Invest. 114:828–836. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Holland AM, Góñez LJ, Naselli G, Macdonald
RJ and Harrison LC: Conditional expression demonstrates the role of
the homeodomain transcription factor Pdx1 in maintenance and
regeneration of beta-cells in the adult pancreas. Diabetes.
54:2586–2595. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guz Y, Montminy MR, Stein R, Leonard J,
Gamer LW, Wright CV and Teitelman G: Expression of murine STF-1, a
putative insulin gene transcription factor, in beta cells of
pancreas, duodenal epithelium and pancreatic exocrine and endocrine
progenitors during ontogeny. Development. 121:11–18.
1995.PubMed/NCBI
|
|
18
|
Peshavaria M, Gamer L, Henderson E,
Teitelman G, Wright CV and Stein R: XIHbox 8, an endoderm-specific
Xenopus homeodomain protein, is closely related to a mammalian
insulin gene transcription factor. Mol Endocrinol. 8:806–816.
1994.PubMed/NCBI
|
|
19
|
Stoffers DA, Desai BM, DeLeon DD and
Simmons RA: Neonatal exendin-4 prevents the development of diabetes
in the intrauterine growth retarded rat. Diabetes. 52:734–740.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Holst JJ: Glucagonlike peptide 1: a newly
discovered gastrointestinal hormone. Gastroenterology.
107:1848–1855. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Holst JJ, Ørskov C, Nielsen OV and
Schwartz TW: Truncated glucagon-like peptide I, an
insulin-releasing hormone from the distal gut. FEBS Lett.
211:169–174. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kreymann B, Williams G, Ghatei MA and
Bloom SR: Glucagon-like peptide-1 7–36: a physiological incretin in
man. Lancet. 2:1300–1304. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Flint A, Raben A, Astrup A and Holst JJ:
Glucagon-like peptide 1 promotes satiety and suppresses energy
intake in humans. J Clin Invest. 101:515–520. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gutzwiller JP, Göke B, Drewe J, Hildebrand
P, Ketterer S, Handschin D, Winterhalder R, Conen D and Beglinger
C: Glucagon-like peptide-1 is a physiologic regulator of food
intake in humans. Gut. 44:81–86. 1999. View Article : Google Scholar
|
|
25
|
Parlevliet ET, de Leeuw van Weenen JE,
Romijn JA and Pijl H: GLP-1 treatment reduces endogenous insulin
resistance via activation of central GLP-1 receptors in mice fed a
high-fat diet. Am J Physiol Endocrinol Metab. 299:E318–E324.
2010.PubMed/NCBI
|
|
26
|
Zhang C, Moriguchi T, Kajihara M, Esaki R,
Harada A, Shimohata H, Oishi H, Hamada M, Morito N, Hasegawa K, et
al: MafA is a key regulator of glucose-stimulated insulin
secretion. Mol Cell Biol. 25:4969–4976. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Corcoran RB, Contino G, Deshpande V,
Tzatsos A, Conrad C, Benes CH, Levy DE, Settleman J, Engelman JA
and Bardeesy N: STAT3 plays a critical role in KRAS-induced
pancreatic tumorigenesis. Cancer Res. 71:5020–5029. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tsuang W, Navaneethan U, Ruiz L, Palascak
JB and Gelrud A: Hypertriglyceridemic pancreatitis: presentation
and management. Am J Gastroenterol. 104:984–991. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cedernaes J, Alsiö J, Västermark A,
Risérus U and Schiöth HB: Adipose tissue stearoyl-CoA desaturase 1
index is increased and linoleic acid is decreased in obesity-prone
rats fed a high-fat diet. Lipids Health Dis. 12:22013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ritzel R, Orskov C, Holst JJ and Nauck MA:
Pharmacokinetic, insulinotropic, and glucagonostatic properties of
GLP-1 [7–36 amide] after subcutaneous injection in healthy
volunteers. Dose-response-relationships. Diabetologia. 38:720–725.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Matsumura T, Itoh H, Watanabe N, Oda Y,
Tanaka M, Namba M, Kono N, Matsuyama T, Komatsu R and Matsuzawa Y:
Glucagonlike peptide-1(7–36)amide suppresses glucagon secretion and
decreases cyclic AMP concentration in cultured In-R1-G9 cells.
Biochem Biophys Res Commun. 186:503–508. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Friedrichsen BN, Neubauer N, Lee YC, Gram
VK, Blume N, Petersen JS, Nielsen JH and Møldrup A: Stimulation of
pancreatic beta-cell replication by incretins involves
transcriptional induction of cyclin D1 via multiple signalling
pathways. J Endocrinol. 188:481–492. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schwasinger-Schmidt T, Robbins DC,
Williams SJ, Novikova L and Stehno-Bittel L: Long-term liraglutide
treatment is associated with increased insulin content and
secretion in β-cells, and a loss of α-cells in ZDF rats. Pharmacol
Res. 76:58–66. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nauck MA, Hompesch M, Filipczak R, Le TD,
Zdravkovic M and Gumprecht J; NN2211-1499 Study Group: Five weeks
of treatment with the GLP-1 analogue liraglutide improves glycaemic
control and lowers body weight in subjects with type 2 diabetes.
Exp Clin Endocrinol Diabetes. 114:417–423. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Del Guerra S, Lupi R, Marselli L, Masini
M, Bugliani M, Sbrana S, Torri S, Pollera M, Boggi U, Mosca F, et
al: Functional and molecular defects of pancreatic islets in human
type 2 diabetes. Diabetes. 54:727–735. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Petersen HV, Serup P, Leonard J, Michelsen
BK and Madsen OD: Transcriptional regulation of the human insulin
gene is dependent on the homeodomain protein STF1/IPF1 acting
through the CT boxes. Proc Natl Acad Sci USA. 91:10465–10469. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Miller CP, McGehee RE Jr and Habener JF:
IDX-1: a new homeodomain transcription factor expressed in rat
pancreatic islets and duodenum that transactivates the somatostatin
gene. EMBO J. 13:1145–1156. 1994.PubMed/NCBI
|
|
38
|
Wang X, Cahill CM, Piñeyro MA, Zhou J,
Doyle ME and Egan JM: Glucagon-like peptide-1 regulates the beta
cell transcription factor, PDX-1, in insulinoma cells.
Endocrinology. 140:4904–4907. 1999. View Article : Google Scholar : PubMed/NCBI
|
